Section of Anatomic Pathology, Department of Haematology and Oncology L e A. Seragnoli University of Bologna, Bellaria Hospital, 40139 Bologna, Italy.
Hum Pathol. 2012 Oct;43(10):1627-37. doi: 10.1016/j.humpath.2011.12.003. Epub 2012 Mar 23.
It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.
评估垂体腺瘤在初次就诊时的复发和进展潜能较为困难。世界卫生组织内分泌肿瘤分类提示,周围结构侵袭、初次就诊时的肿瘤大小、有丝分裂指数升高、Ki-67 标记指数>3%和广泛的 p53 表达是侵袭性行为的指标。然而,Ki-67 和 p53 标记指数的评估受到观察者间变异性的影响,且其截断值存在争议。在本研究中,我们通过数字图像分析评估了 166 例接受了至少 6 年随访的垂体腺瘤患者的 Ki-67 和 p53 蛋白标记指数的预后价值及其与临床和影像学参数的相关性,以评估其对垂体腺瘤复发和进展潜能的影响。使用受试者工作特征曲线和分类回归树分析对数据进行了分析。结果表明,在未分层数据集中,常用的 Ki-67 指数 3%的截断值具有较高的特异性(89.5%),但敏感性较低(53.8%)。p53 标记指数的受试者工作特征曲线分析结果不佳。相反,分类回归树分析得到的树表明,每种垂体腺瘤亚型都有特定的预后因素。具体来说,Ki-67 标记指数是无功能、促肾上腺皮质激素和催乳素腺瘤的有用预后因素,但具有不同的截断值。总之,我们的研究强调,垂体腺瘤这一术语包括不同类型的肿瘤,每种肿瘤都有特定的预后因素。